Skip to main content

Supplementary Table 3 Polymorphisms/mutations in candidate genes for asthma and related phenotypes

From: Interactions between genes and environmental factors in asthma and atopy: new developments

Chromosomal

   

Single nucleotide

Phenotype

 

Functional

 

location

Number*

Molecule

 

polymorphism/mutation

related

Population

(in vitro)

Reference

1p32

1

Histamine-N-

 

C314T (Thr105Ile)

Asthma

Caucasian

Yes

[28]

  

methyl-transferase

      

2q33-34

2

CD28

 

T19int3C

None

Caucasian

 

[S33]

  

CTLA-4

 

A49G

None

Caucasian

 

[S33]

    

C-318T

None

Caucasian

  

3p21

3

CCR5

 

CC5-Δ32

Asthma

Caucasian

Yes

[40]

     

No Association

British/Australian

 

[41]

5q31-34

4

IL-4

 

C-590T

Total IgE

Japanese

Yes

[S34]

    

(= C-589T)

Total IgE

American

 

[S35]

     

Specific IgE, wheeze

Australian

 

[S36]

     

FEV1

Caucasian

 

[S37]

     

Atopic dermatitis

Japanese

 

[S38]

     

None

Caucasian

 

[S39]

    

C+33T

Total IgE

Japanese

 

[S40]

 

5

IL-5

 

None

 

Australian

 

[S41]

 

6

IL-13

 

C-1055T

Allergic asthma

Dutch

 

[S42]

   

identical

     
    

C-1112T

Total IgE

American/German

 

[19]

    

A-1512C

    
    

C1923T

    
    

G2525A

    
    

C2580A

    
    

C2749T

    
    

Arg130Gln

    
   

identical

G4257A

High IgE, atopic dermatitis

German

 

[S43]

    

Gln110Arg

Atopic and intrinsic

British/Japanese

 

[S44]

     

asthma

   
 

7

β2-AR

 

G-1023A

    
    

C-709A

    
    

G-654A

    
    

C-468G

    
    

C-406T

    
    

T-367C

Drug response

Caucasian/African American

Yes

[24]

    

T-47C

(Haplotype studies)

Asian/Hispanic-Latino

  
    

T-20C

    
    

G46A (= Gly16Arg)

    
    

C79G (= Gln27Glu)

    
    

G252A

    
    

C491T (= Thr164Ile)

    
    

C523A

    
    

Gly16Arg

Drug response

American

Yes

[27]

     

FEV1 and FVC

Hutterites

 

[S45]

     

Asthma severity

Not specified

 

[S46]

    

Gly16Arg

Nocturnal asthma

American

 

[25]

     

Steroid-dependent asthma

American

 

[S47]

     

None

German

 

[S48]

     

Drug response

Not specified

 

[S49]

    

Gln27Glu

Drug response

American

Yes

[27]

     

Drug response

Not specified

 

[S49]

     

None

German

 

[S48]

     

Total IgE

Caucasian

 

[S50]

     

FEV1

British

 

[S51]

 

8

IRF-1

 

-300 G/T

None

Japanese

 

[S52]

    

4396 A/G

None

   
    

6355 G/A

None

   
 

9

CD14

 

-159 C → T

Total IgE

Caucasian

 

[S53]

     

None

Hispanic

 

[S53]

     

Total IgE

British

 

[S54]

     

None

Japanese

 

[S54]

5q35

10

LTC4 synthase

 

-444 C

Aspirin-induced asthma

Caucasian

Yes

[30]

     

None

American

No

[S55]

6p21

11

HLA-II

  

Specific IgE

Multiple

 

[S56]

  

TNF

 

-308 TNF2

BHR

Caucasian

 

[S57]

  

LT-α

 

LT alpha NcoI*1/

Asthma

British

 

[S58]

    

TNF-308*2 haplotype

    
    

-308 TNF1

Asthma

Australian

 

[S59]

    

LT-alpha*2

Asthma

   

6p21-12

24

PAF-acetyl-hydrolase

 

Ile198Thr

Atopic Asthma/

German/British

Yes

[S60]

     

total IgE

   
    

Ala379Val

Asthma/specific IgE

 

Yes

 
    

Arg92His

None

 

Yes

 

10

12

5-LO (promoter)

 

(GGGCGG)n = 3–6

Drug Response

Not specified

Yes

[29]

11q12-13

14

CC16

 

A38G

Asthma

Australian

 

[S61]

     

None

British/Japanese

 

[S62]

 

15

FcεR1-β

 

lle181Leu

Atopy

British

No

[S63]

      

Japanese

 

[S64]

    

Leu181/Leu183

Atopy, BHR

British/Australian

No

[S65]

     

None

Australian

 

[S51]

    

E237G (= Gly237Glu)

Atopy

Australian

No

[S66]

     

None

Japanese

 

[S67]

    

RsaI_in2*B

Asthma

Australian

 

[S68]

    

RsaI_ex7 (+ RsaI_in2*B)

Total IgE, atopic

Not specified

 

[S69]

     

dermatitis, asthma

   
    

-109C/T

Total IgE

Japanese

 

[S70]

 

13

GSTP1

 

Ile105Val

IgE/Skin Test/FEV1

Caucasian

 

[S71]

12q13

17

STAT6

 

G2964A

Asthma

Japanese

 

[S72]

12q14

16

IFN-γ

 

None

 

Australian/Venezuelan

 

[S73]

12q24

18

NO-synthase 1

 

(AAT)n ≥ 12

Exhaled NO

Mixed

 

[S74]

14p11

19

TCR

 

VA8.1(*)2

Specific IgE

Caucasian

 

[S75]

 

20

Mast cell chymase

 

MCC BstXI

Eczema

Japanese

 

[S76]

     

Total IgE

Not specified

 

[S77]

     

None

Japanese

 

[S78]

     

None

Italian

 

[S79]

     

Atopic dermatitis

Japanese

 

[S80]

     

With high IgE

   

16p12-p11

21

IL-4Rα

 

Q576R (= Arg551Gln)

Atopy, high IgE

American

Yes

[S81]

     

Asthma severity (FEV1)

American

 

[S82]

     

None

Italian

 

[S83]

     

Atopic dermatitis

Japanese

 

[S84]

     

Low IgE

German

Yes

[20]

    

S503P (= 478Pro)

Low IgE

  

[20]

    

E400A

None

   
    

C431R

None

   
    

Ile50Val

IgE/atopic asthma

Japanese

Yes

[S85]

     

None

Japanese

 

[S86]

    

Ile50Val

    
    

Ser727Ala

    
    

Glu375Ala

    
    

Cys406Arg

Atopy/asthma

Hutterites/Caucasian

 

[21]

    

Ser411Leu

(Haplotype studies)

African American/Hispanic

  
    

Ser761Pro

    
    

Ser478Pro

    
    

Gln551Arg

    

17q11-q12

22

RANTES

 

G-401A

Atopic dermatitis

Caucasian

Yes

[43]

   

identical

     
    

G-403A

Asthma, atopy

Caucasian

 

[44]

Xq

23

IL-13Rα1

 

A1398G

Total IgE

British

 

[S44]

  1. Divergent positions of identical mutations are due to different database accession numbers used for reference. * Numbers refer to molecules in Supplementary Figure 1. Nomenclature as in references. β2-AR, β2 adrenergic receptor; BHR, bronchial hyperresponsiveness; CC16, Clara cell protein 16; CCR5, CC chemokine receptor 5; CD, cluster of differentiation; FcεR1-β, Fc epsilon receptor 1 beta (IgE receptor); FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; GSTP1, glutathione-S-transferase 1; HLA, human leukocyte antigen; IFN, interferon; IL, interleukin; IL-4/13 R, interleukin 4/13 receptor; IRF-1, interferon regulatory factor 1; 5-LO, 5-lipoxygenase; LT, leukotriene; LT-α, lymphotoxin α; LTC4, leukotriene C4 synthase; NO, nitric oxide; PAF, platelet activating factor; RANTES, regulated on activation, normal T cell expressed and secreted; STAT6, signal transducer and activator of transcription 6; TCR, T-cell receptor; TNF, tumor necrosis factor.